Lindsey Thomas, PA
Medical · Oklahoma City, OKNPI 1326575663
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,943 of the $4,405 with a category attached, or 66.8%. 32 manufacturers reported payments, led by Intuitive Surgical at 27.1% of the total.
Across 115 payments — averaging $38.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Atricure, Inc.$497
- Johnson & Johnson$386
- E.r. Squibb & Sons, L.L.C.$256
- Abbott$242
- Abiomed$175
- plus $2K from 26 others
What the payments were for
- Travel & lodging$92821%
- Food & beverage$2,94367%
- Education$53512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,194 |
| Atricure, Inc. | 12 | $497 |
| Johnson & Johnson(4 entities) | 12 | $386 |
| E.r. Squibb & Sons, L.L.C. | 8 | $256 |
| Abbott | 8 | $242 |
| Abiomed | 2 | $175 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $164 |
| Inari Medical, Inc. | 8 | $151 |
| Incyte Corporation | 2 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $132 |
| Actelion Pharmaceuticals US, Inc. | 5 | $124 |
| AbbVie | 5 | $113 |
| Medtronic | 6 | $113 |
| W. L. Gore & Associates, Inc. | 1 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Merck | 4 | $67 |
| Novartis | 3 | $66 |
| LEO Pharma Inc. | 4 | $65 |
| Surmodics, Inc. | 4 | $46 |
| Davol Inc. | 2 | $45 |
| Chiesi USA, Inc. | 2 | $39 |
| Edwards Lifesciences | 1 | $26 |
| AstraZeneca | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| Cvrx, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Impulse Dynamics (USA) Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Organon | 2 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,405 in reported general payments places this provider in the 85th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 13 | $117 |
| ClopidogrelClopidogrel Bisulfate | 24 | $104 |
| Potassium Chloride | 14 | $103 |
| Metoprolol Tartrate | 17 | $58 |
| Furosemide | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Other medical in Oklahoma City
- Mebin ThomasOklahoma City$323K
- Kristine MurrowOklahoma City$81K
- Katelyn PuryearOklahoma City$22K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
- Vy TranOklahoma City$15K
- Jennifer MinshallOklahoma City$11K
- Lindee LedbetterOklahoma City$10K
- Christina HelmsOklahoma City$7K
- John ParmeleeOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.